BOARD of Directors

Stefan Larson, PhD

Stefan is a Partner and member of the Management Committee at Sectoral and is responsible for the company’s venture capital group. He serves as a director on the boards of Apnimed, Pipeline Therapeutics, Prilenia Therapeutics, Amolyt Pharma and Turnstone Biologics. Prior to joining Sectoral, he was an Entrepreneur-in-Residence and later Venture Partner with Versant Ventures, where he led the establishment of their Toronto-based Discovery Engine and was the founding CEO of Northern Biologics. He was also a cofounder of two medical device companies: Perimeter Medical Imaging, and Tornado Spectral Systems. He began his career at McKinsey & Company in San Francisco and Toronto.

Stefan graduated in 1997 from McGill University with a B.Sc. in Biology, and in 1999 from University of Toronto with an M.Sc. in Molecular and Medical Genetics. He completed his Ph.D. in Biophysics at Stanford University in 2004.